Price
No data yet.
Social Signal Score
Analyst Ratings
37 analystsRevenue
$4.06B-7.26%Analyst Estimates
Consensus estimates, not results. Via Financial Modeling Prep.
Company Profile
- CEO
- Kevin J. Hammons
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Employees
- 50,500
- Beta
- 1.86
- Country
- US
- Piotroski score
- 5 / 9 (Middling)
- Altman Z-score
- 2.68
Financials
Revenue
$4.06B-7.3%Net Income
$70.00MEBITDA
$325.00M-21.5%Free Cash Flow
$12.00M-25.0%EPS (diluted)
$0.51Shares Outstanding (diluted)
136.00M+22.6%Operating Expenses
$1.24BCash & Debt
$149.00MReturn of Capital
$0.00Revenue by Segment (annual)
$10.23BDividend per Share
$0.21Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $12.48B | $509.00M | $3.80 |
| 2024 | $12.63B | $-516.00M | $-3.90 |
| 2023 | $12.49B | $-133.00M | $-1.02 |
| 2022 | $12.21B | $46.00M | $0.36 |
| 2021 | $12.37B | $230.00M | $1.82 |
| 2020 | $11.79B | $511.00M | $4.42 |
| 2019 | $13.21B | $-590.00M | $-5.19 |
| 2018 | $14.15B | $-788.00M | $-6.99 |
| 2017 | $15.35B | $-2.46B | $-22.00 |
| 2016 | $18.44B | $-1.72B | $-15.55 |
| 2015 | $19.44B | $158.00M | $1.38 |
| 2014 | $18.64B | $92.00M | $0.82 |
| 2013 | $13.00B | $141.20M | $1.51 |
| 2012 | $13.03B | $265.64M | $2.98 |
Valuation
Project earnings forward and see what return today's price implies.
Seeded from CYH's reported EPS growth of 1.9% a year over 13 years.
- EPS in 5 years
- $4.17
- Implied price
- $75.12
- Return from $2.76
- 93.6% a year
To earn 15.0% a year on these assumptions you'd need to buy at $37.35 — today's price is already 92.6% below that.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 12 | 15 | 18 | 21 | 24 |
|---|---|---|---|---|---|
| -8.1% | 61.0% | 68.4% | 74.6% | 80.1% | 85.0% |
| -3.1% | 69.8% | 77.5% | 84.1% | 89.9% | 95.0% |
| 1.9% | 78.5% | 86.7% | 93.6% | 99.7% | 105.1% |
| 6.9% | 87.3% | 95.9% | 103.1% | 109.5% | 115.2% |
| 11.9% | 96.1% | 105.0% | 112.6% | 119.3% | 125.2% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Signal Score (90d)
100+25.00%Social Signal Score
Mentions (4)
- Newszacks.com·10d ago·Neutral
Can Community Health Sustain Growth as Elective Demand Softens? CYH's volume growth faces pressure from softer elective procedures and payer mix, while a recovery in demand could help margins and cash flow.
View source ↗ - Newsbusinesswire.com·33d ago·Neutral
Community Health Systems to Participate in the Wells Fargo 21st Annual Healthcare Conference FRANKLIN, Tenn.--(BUSINESS WIRE)---- $CYH--Community Health Systems, Inc. (NYSE:CYH) today announced that management will participate in the Wells Fargo 21st Annual Healthcare Conference to be held September 8-10, 2026. The Company will host a fireside chat presentation on Wednesday, September 9, 2026, at 4:30 p.m. ET, 3:30 p.m. CT. The fireside chat presentation will be available to investors via a live…
View source ↗ - Newszacks.com·45d ago·Neutral
Community Health Systems (CYH) Up 7.2% Since Last Earnings Report: Can It Continue? Community Health Systems (CYH) reported earnings 30 days ago. What's next for the stock?
View source ↗ - Newszacks.com·49d ago·Negative
Community Health Trades at a Deep Discount to Peers: Hold or Fold? CYH trades at a deep discount to peers as acquisitions, cost control and debt reduction progress, but cash flow remains a concern.
View source ↗
Earnings
Thu, Oct 22(in 2 weeks)
Consensus estimate $-0.29 per share
Typical surprise -83.4% (median, so one quarter with a near-zero estimate can't distort it)
- Wed, Jul 22$-0.19 vs $-0.10miss
- Tue, Apr 21$-0.48 vs $-0.11miss
- Wed, Feb 18$-0.01 vs $-0.20beat
- Thu, Oct 23$1.27 vs $-0.28beat
- Wed, Jul 23$-0.05 vs $0.05miss
- Wed, Apr 23$-0.03 vs $-0.10beat
Estimates and results for CYH via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Insider trading
Open-market buys and sells by CYH officers and directors.
- Bought
- —
- Sold
- $118k
0 trades
1 trade
- Jennings William Norrissold
99 further Form 4 entries are share awards, option exercises or shares withheld for tax. Those are compensation, not trades, so they are excluded above. Buying is the stronger signal: an insider spends their own money for one reason. Selling has many innocent explanations — tax, diversifying, a house — so it says far less than it appears to. Via SEC filings.
Congress trades
No disclosed congressional trades in CYH.
Self-reported filings, amounts as brackets. Via Senate/House disclosures.